These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35259169)

  • 21. Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    Doyle K; Teran RA; Reefhuis J; Kerins JL; Qiu X; Green SJ; Choi H; Madni SA; Kamal N; Landon E; Albert RC; Pacilli M; Furtado LE; Hayden MK; Kunstman KJ; Bethel C; Megger L; Fricchione MJ; Ghinai I
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1195-1200. PubMed ID: 34473687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A compartmental model that predicts the effect of social distancing and vaccination on controlling COVID-19.
    Dashtbali M; Mirzaie M
    Sci Rep; 2021 Apr; 11(1):8191. PubMed ID: 33854079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Silva PJS; Sagastizábal C; Nonato LG; Struchiner CJ; Pereira T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34408076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyzing the COVID-19 vaccination behavior based on epidemic model with awareness-information.
    Zuo C; Zhu F; Meng Z; Ling Y; Zheng Y; Zhao X
    Infect Genet Evol; 2022 Mar; 98():105218. PubMed ID: 35066164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The COVID-19-Cancer Connection.
    Boyle DA
    Clin J Oncol Nurs; 2021 Jun; 25(3):235-236. PubMed ID: 34019020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    Fowlkes A; Gaglani M; Groover K; Thiese MS; Tyner H; Ellingson K;
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1167-1169. PubMed ID: 34437521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views.
    Prieto Curiel R; González Ramírez H
    Sci Rep; 2021 Mar; 11(1):6626. PubMed ID: 33758218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the Number of COVID-19 Cases and Impact of New COVID-19 Variants and Vaccination on the Population in Kerman, Iran: A Mathematical Modeling Study.
    Nakhaeizadeh M; Chegeni M; Adhami M; Sharifi H; Gohari MA; Iranpour A; Azizian M; Mashinchi M; Baneshi MR; Karamouzian M; Haghdoost AA; Jahani Y
    Comput Math Methods Med; 2022; 2022():6624471. PubMed ID: 35495892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A data-driven model for COVID-19 pandemic - Evolution of the attack rate and prognosis for Brazil.
    Rocha Filho TM; Moret MA; Chow CC; Phillips JC; Cordeiro AJA; Scorza FA; Almeida AG; Mendes JFF
    Chaos Solitons Fractals; 2021 Nov; 152():111359. PubMed ID: 34483500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal control-based vaccination and testing strategies for COVID-19.
    Olivares A; Staffetti E
    Comput Methods Programs Biomed; 2021 Nov; 211():106411. PubMed ID: 34600408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mild and asymptomatic infections on COVID-19 vaccines performance: A modeling study.
    Aguiar M; Van-Dierdonck JB; Mar J; Stollenwerk N
    J Adv Res; 2022 Jul; 39():157-166. PubMed ID: 35777906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of early detection and vaccination strategy in COVID-19 eradication program in Jakarta, Indonesia.
    Aldila D; Samiadji BM; Simorangkir GM; Khosnaw SHA; Shahzad M
    BMC Res Notes; 2021 Apr; 14(1):132. PubMed ID: 33845887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective mathematical modelling of health passes during a pandemic.
    Hohenegger S; Cacciapaglia G; Sannino F
    Sci Rep; 2022 Apr; 12(1):6989. PubMed ID: 35484143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout.
    Gozzi N; Bajardi P; Perra N
    PLoS Comput Biol; 2021 Sep; 17(9):e1009346. PubMed ID: 34506478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamical regulations on mobility and vaccinations for controlling COVID-19 spread.
    Rajakaruna M; Rajakaruna H; Rajakaruna R
    Sci Rep; 2022 Mar; 12(1):3554. PubMed ID: 35241699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.